Jacoti presents DuoTone® pure-tone procedure at HeAL 2016

June 2nd, 2016·PDF VERSION
Logo HeAL 2016 Conference, Hearing Across the Lifespan

Contact our Press Officer for more information or to arrange an interview with our team.

press@jacoti.com

The NHS and AHS Conferences (termed HEAL Conferences, since 2012) have become the place where a broad community investigating all components of hearing care across the lifespan can work together to merge contemporary research findings with cutting-edge clinical practice.

HEAL 2016 - Hearing Across the Lifespan: Program >

Abstract: DuoTone® validated as a pure tone audiometry procedure for mobile electronic platforms

Standard pure tone audiometry (PTA) requires an audiologist to control the stimuli and the responses. DuoTone® is a new method for conducting pure tone audiometry and is based on an automated adaptive procedure that enables self-testing by a layperson, without the assistance of an audiologist. The subject being tested has to decide what sound was presented: one long-low tone, three short-high tones or nothing (silence). Two adaptive procedures - one for the lower and one for the higher frequency - control the stimulus intensity and finally result in two-tone thresholds at the end. Jacoti Hearing Center (JHC) has implemented DuoTone® for mobile consumer electronic devices, specifically for the iPhones and iPods, and is calibrated for the Apple Earpods.

This paper presents the results of calibration tests and a clinical validation study comparing DuoTone® with standard PTA in clinical test situations. In this clinical validation study, the DuoTone® thresholds obtained in a group of persons (average age 59.2, range 31-86 y) having various degrees of hearing loss (range 0 to 80 dB HL) at 4 test frequencies (500, 1k, 2k and 4k) were compared with classical pure tone audiometry thresholds.

In the clinical validation study the average difference between standard PTA and DuoTone® thresholds, across all test frequencies and all subjects, was 1.9 dB with a standard deviation of 7.4 dB.

Conclusions: JHC implementation of DuoTone® in consumer electronic devices, such as mobile phones, has proven to be a clinically valid medical device without statistically significant precision differences with standard audiometers. DuoTone® has proven to be a valid procedure to measure pure-tone hearing thresholds that can replace standard PTA in clinical test situations and DuoTone® can be used as a self-testing or self-screening tool running on mobile consumer electronic platforms.